AltPep is a biomedical startup with a breakthrough approach for diagnosing and treating amyloid diseases

We are currently focusing on CNS disorders, in particular Alzheimer’s Disease.

Learn more

Our platform

The AltPepTM Platform is based on a collection of de novo designed synthetic peptides. The growing library is an arsenal that specifically targets the root causes of disease at the molecular level.


For the early detection and tracking of amyloid diseases Diagnostics using plasma and CSF


These peptides target the toxic Aβ oligomers, neutralizing toxicity and inhibiting the disease
Learn more